You are currently viewing a new version of our website. To view the old version click .
Medical Sciences Forum
  • Abstract
  • Open Access

7 November 2022

Synthesis of 4-acetamido-octahydrochromene Derivatives Based on (–)-Isopulegol—Promising Analgesic Agents †

,
,
and
N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9 Akademika Lavrentieva Ave., 630090 Novosibirsk, Russia
*
Author to whom correspondence should be addressed.
Presented at the 8th International Electronic Conference on Medicinal Chemistry, 1–30 November 2022; Available online: https://ecmc2022.sciforum.net/.
This article belongs to the Proceedings The 8th International Electronic Conference on Medicinal Chemistry

Abstract

Selective modification of natural compounds is one of the most important ways to develop and search for new biologically active substances of various structural types. It was found earlier that some compounds with octahydro-2H-chromene scaffolds synthesized from monoterpenoid (–)-isopulegol demonstrated promising biological activity, e.g., analgesic, and antiviral activities, inhibitory activity against DNA repair enzyme Tdp1. The flexible method for the synthesis of octahydro-2H-chromenes derivatives is the Prins cyclization. This reaction could serve also as an initiator of a three-component tandem reaction. For example, the sequence of the Prins and Ritter reactions is one of the best synthetic methods to efficiently build six-membered fragment of 4-amidotetrahydropyran in a one-pot single step reaction. In this work we have developed a method for synthesis of chiral 4-acetamido-octahydro-2H-chromenes. We used tandem Prins-Ritter reaction between (–)-isopulegol and a set of ketones in acetonitrile. Desired products were formed as a mixture of 4R/4S diastereomers, where 4S one is a major isomer. Development of new analgesic agents with high activity and low toxicity is important task. It is known that the heterocyclic compounds synthesized from (–)-isopulegol exhibit analgesic activity. In the study of the analgesic activity of the synthesized compounds in vivo, we found that a number of derivatives showed high analgesic activity reliably and not inferior in efficiency to the reference drug sodium diclofenac administered at a similar dose.

Supplementary Materials

Author Contributions

Conceptualization, N.L.-Z. and K.V.; methodology, N.L.-Z. and M.K.; investigation, N.L.-Z. and V.K.; writing—original draft preparation, N.L.-Z.; writing—review and editing, K.V. All authors have read and agreed to the published version of the manuscript.

Funding

Russian state-funded project for NIOCh SB RAS (number 1021051703312-0-1.4.1).

Institutional Review Board Statement

Work with animals was carried out in strict accordance with the Order of the Ministry of Health of the Russian Federation No. 199n dated 1 April 2016 “Good Laboratory Practice” and the provisions of Directive 2010/63/EU on the protection of animals used for scientific purposes of the European Parliament and the Council of the European Union of 22 September 2010.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.